Atea Pharmaceuticals, Inc.(NasdaqGS:AVIR) dropped from Russell 3000E Growth Index
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.685 USD | -3.53% | -0.41% | +20.82% |
05-14 | Atea Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-14 | Transcript : Atea Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.82% | 322M | |
+10.52% | 115B | |
+12.17% | 106B | |
-5.85% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.56% | 17.56B | |
-40.50% | 17.32B | |
+6.46% | 14.03B | |
+30.42% | 12.13B |
- Stock Market
- Equities
- AVIR Stock
- News Atea Pharmaceuticals, Inc.
- Atea Pharmaceuticals, Inc.(NasdaqGS: AVIR) dropped from Russell 3000E Growth Index